Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
6.77
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)-0.87 Insider Own8.79% Shs Outstand31.15M Perf Week-1.17%
Market Cap212.58M Forward P/E69.44 EPS next Y0.10 Insider Trans0.84% Shs Float28.64M Perf Month55.99%
Income-22.29M PEG- EPS next Q-0.11 Inst Own12.79% Short Float11.28% Perf Quarter41.04%
Sales25.18M P/S8.44 EPS this Y-16.26% Inst Trans7.79% Short Ratio11.72 Perf Half Y18.36%
Book/sh0.73 P/B9.33 EPS next Y110.10% ROA-40.96% Short Interest3.23M Perf Year64.72%
Cash/sh1.26 P/C5.38 EPS next 5Y- ROE-129.63% 52W Range2.68 - 8.22 Perf YTD38.45%
Dividend Est.- P/FCF- EPS past 5Y30.59% ROI-81.15% 52W High-17.65% Beta4.01
Dividend TTM- Quick Ratio1.63 Sales past 5Y339.72% Gross Margin95.81% 52W Low152.61% ATR (14)0.51
Dividend Ex-Date- Current Ratio1.63 EPS Y/Y TTM26.32% Oper. Margin-94.76% RSI (14)68.94 Volatility10.86% 9.54%
Employees102 Debt/Eq0.25 Sales Y/Y TTM886.81% Profit Margin-88.52% Recom1.00 Target Price21.00
Option/ShortYes / Yes LT Debt/Eq0.22 EPS Q/Q91.92% Payout- Rel Volume0.00 Prev Close6.77
Sales Surprise14.04% EPS Surprise77.78% Sales Q/Q1159.30% EarningsFeb 29 AMC Avg Volume275.68K Price6.77
SMA2014.67% SMA5042.19% SMA20047.96% Trades Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Jan-05-24Initiated Cantor Fitzgerald Overweight $8
Oct-26-22Initiated Ladenburg Thalmann Buy $15
Dec-26-18Downgrade Maxim Group Buy → Hold
Jan-26-18Reiterated H.C. Wainwright Buy $6.50 → $8.60
Sep-15-17Reiterated H.C. Wainwright Buy $2.15 → $6.50
Feb-13-17Resumed Rodman & Renshaw Buy $14
Jul-06-16Resumed H.C. Wainwright Buy $13
Jun-15-16Initiated ROTH Capital Buy
Mar-25-24 09:55AM
Mar-21-24 08:30AM
Mar-07-24 09:55AM
Mar-06-24 08:30AM
Mar-02-24 08:17AM
06:06AM Loading…
Mar-01-24 06:06AM
Feb-29-24 04:42PM
04:35PM
04:05PM
Feb-27-24 08:30AM
Feb-22-24 08:30AM
Feb-20-24 08:30AM
Jan-24-24 09:15AM
Dec-11-23 09:00AM
Nov-16-23 08:28AM
04:30PM Loading…
Nov-14-23 04:30PM
04:05PM
Nov-07-23 09:15AM
Nov-02-23 10:00AM
Oct-25-23 09:35AM
Oct-24-23 09:35AM
Oct-19-23 04:01PM
Oct-10-23 09:00AM
Sep-29-23 07:35AM
07:30AM
Sep-06-23 09:00AM
Aug-08-23 01:44PM
Aug-07-23 04:51PM
04:05PM
Aug-02-23 04:01PM
08:30AM Loading…
Jul-24-23 08:30AM
Jul-13-23 08:30AM
Jul-06-23 12:27PM
Jun-30-23 09:25AM
Jun-13-23 09:15AM
Jun-09-23 11:28AM
Jun-07-23 09:15AM
May-13-23 09:18AM
May-11-23 04:22PM
04:01PM
May-04-23 09:00AM
Apr-27-23 09:00AM
Mar-23-23 09:25AM
Mar-20-23 11:27AM
Mar-18-23 03:12AM
Mar-15-23 04:01PM
Mar-08-23 09:00AM
Mar-02-23 09:15AM
Feb-16-23 09:25AM
Jan-25-23 08:00AM
Jan-19-23 04:05PM
Jan-12-23 12:55PM
09:26AM
Jan-11-23 12:00PM
Dec-10-22 07:46AM
Nov-30-22 10:35AM
Nov-13-22 07:18AM
Nov-10-22 05:15PM
04:30PM
04:01PM
Nov-03-22 04:01PM
Oct-06-22 09:00AM
Sep-07-22 08:00AM
Aug-10-22 04:05PM
Aug-03-22 08:00AM
Jul-19-22 09:15AM
Jun-27-22 07:00AM
Jun-17-22 09:00AM
May-25-22 09:00AM
May-18-22 09:00AM
May-10-22 04:01PM
May-03-22 08:30AM
May-02-22 10:08AM
Mar-29-22 09:00AM
Mar-28-22 12:06PM
08:30AM
Mar-11-22 08:00AM
Mar-10-22 04:01PM
Mar-03-22 09:15AM
Mar-02-22 09:00AM
Feb-15-22 06:27AM
Jan-25-22 02:58PM
11:06AM
05:00AM
Dec-30-21 07:57AM
Dec-13-21 09:15AM
Nov-19-21 10:00AM
Nov-17-21 05:24AM
Nov-12-21 09:15AM
Nov-09-21 06:45PM
04:05PM
Nov-03-21 07:30AM
Nov-02-21 04:05PM
Sep-24-21 09:28AM
07:00AM
Sep-22-21 04:05PM
Sep-07-21 09:00AM
Sep-02-21 08:30AM
Aug-19-21 09:45AM
Aug-12-21 04:01PM
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bergmann AnthonyCHIEF FINANCIAL OFFICEROct 23 '23Option Exercise1.392,1783,0272,381Oct 24 09:25 AM
Musket David BDirectorOct 12 '23Buy2.754101,12831,536Oct 13 01:59 PM
COLLIER EARL M JRDirectorOct 10 '23Buy2.8310,00028,30026,856Oct 12 09:15 AM
Musket David BDirectorOct 09 '23Buy2.825,08314,33431,126Oct 11 09:15 AM
Auwaerter Paul GisbertDirectorOct 06 '23Buy2.845,00014,2005,000Oct 10 09:15 AM
Musket David BDirectorOct 04 '23Buy2.902,5007,25026,043Oct 06 09:15 AM
Litvack FrankDirectorAug 14 '23Option Exercise1.3920,74828,840137,633Aug 16 05:00 PM
Marban LindaCHIEF EXECUTIVE OFFICERMay 12 '23Option Exercise1.3920,74928,841198,604May 16 07:00 PM
Avat XavierFormer CBOApr 17 '23Sale4.3514,77264,2580Apr 27 05:28 PM
Avat XavierFORMER CHIEF BUSINESS OFFICERApr 05 '23Option Exercise3.4684,791293,37784,791Apr 07 05:00 PM